95262-01-4

Usage

InChI:InChI=1/C10H11NO3/c1-7-2-4-8(5-3-7)11-9(12)6-10(13)14/h2-5H,6H2,1H3,(H,11,12)(H,13,14)

Upstream product

• 72324-44-8 ethyl 2-(p-methylanilido)ethanoate 
• 141-82-2 malonic acid 
• 106-49-0 p-toluidine 
• 5469-94-3 N,N'-bis(4-methylphenyl)malonamide 
• 2033-24-1 cycl-isopropylidene malonate 
• 105-53-3 diethyl malonate 

Downstream Products

• 108620-57-1 ((Ξ)-furfurylidene)-malonic acid mono-p-toluidide 
• 72324-44-8 ethyl 2-(p-methylanilido)ethanoate 
• 74957-51-0 3ξ-benzo[1,3]dioxol-5-yl-acrylic acid p-toluidide 
• 1677-44-7 4-hydroxy-6-methylquinolin-2(1H)-one 

Relevant academic research and scientific papers

SUBSTITUTED AZOLE DIONE COMPOUNDS WITH ANTIVIRAL ACTIVITY

Provided herein are methods of using substituted azole dione compounds for treatment of viral infections.

Clean and convenient one-pot synthesis of 4-hydroxycoumarin and 4-hydroxy-2-quinolinone derivatives

A simple, efficient, and environmentally friendly procedure has been developed for the reaction of Meldrum's acid with phenol, substituted phenols, aniline, or substituted anilines with Eaton's reagent (phosphoric anhydride+methylsulfonic acid) as cyclization reagent. 4-Hydroxycoumarins and 4-hydroxy-2-quinolinones were synthesized in moderate yields by carrying out the reaction in solvent-free, convenient, and clean one-pot preparation.

Compounds with anti-cancer activity

Novel substituted azole diones are provided that kill cells, suppress cell proliferation, suppress cell growth, abrogate the cell cycle G2 checkpoint and/or cause adaptation to G2 cell cycle arrest. Methods of making and using the invention compounds are provided. The invention provides substituted azole diones to treat cell proliferation disorders. The invention includes the use of substituted azole diones to selectively kill or suppress cancer cells without additional anti-cancer treatment. The invention includes the use of cell cycle G2-checkpoint-abrogating substituted azole diones to selectively sensitize cancer cells to DNA damaging reagents, treatments and/or other types of anti-cancer reagents.